Promoting trust: Cuttsy+Cuttsy become a PIF Tick accredited agency
May 5, 2022 | Accredited information, PIF tick, health literacy
Cuttsy+Cuttsy join a host of noteworthy healthcare charities and institutions as one of the first healthcare communications agencies to receive the Patient Information Forum’s seal of approval – the PIF Tick.
Living through the COVID-19 pandemic brought with it many unexpected consequences. Among them was the rise of the ‘digital infodemic’. Society found itself bombarded with a vast range of often conflicting health information, produced by different sources, and frequently released without a formal review process. It was hard to know who and what to trust. Added to this, much of the well-researched and peer-reviewed medical information included in this deluge was not underpinned by the principles of health literacy.
Throughout this time, Cuttsy+Cuttsy proved themselves determined to support and uphold trusted, patient-centric health information, and this determination has been recognised. Cuttsy+Cuttsy join a host of noteworthy healthcare charities and institutions as one of the first healthcare communications agencies to receive the Patient Information Forum’s seal of approval – the PIF Tick. A PIF Tick quality mark is assigned to an organisation whose health information meets ten specific criteria points covering aspects such as design, usability, accessibility and user engagement. Information also undergoes a rigorous, auditable production process, making the PIF Tick an industry-wide symbol that can be trusted by everyone.
PIF sets out 10 criteria for trustworthy health information, many of which align closely to Cuttsy+Cuttsy’s values as an organisaion. Ensuring patients are involved in the process of developing health information is a key element in their work. Cross industry collaboration from healthcare professionals to patients ensures all voices are equally heard and valued. This collective approach also guarantees projects and services meet an ‘identified user need’.
Liz Walder PhD, Content Director at Cuttsy+Cuttsy commented; “It is wonderful to have earned an accreditation that aligns so seamlessly with our values as a company. Perhaps the most rewarding part is in knowing no fundamental shifts in attitudes or processes had to be taken to be recognised with a PIF Tick. Our determination to provide trusted and accessible health information for healthcare professionals through to patients has always been there. But now we have a PIF Tick to guide them to it too”.
This content was provided by Cuttsy + Cuttsy
Company Details
Latest Content from Cuttsy + Cuttsy
Long-term clinical trial engagement is a behavioural challenge – not just an informational one
Explore why long-term clinical trial engagement is a behavioural challenge, showing how proactive support from site teams can help participants stay connected, confident and committed throughout a study.
Patients are telling the truth — just not to you
Patients are often most honest outside the clinic—revealing vital insights that can help clinical trial teams build trust, improve participation and collect better data.
When what matters to patients is hard to measure
Patient-relevant outcomes sit at the heart of the EU HTA reforms, but ensuring they reflect lived experience requires you to look beyond what traditional clinical endpoints measure.
Permission to pause: making treatment breaks part of the cancer care conversation
Exploring how empathetic, patient-centred communication can make planned treatment breaks easier to discuss as part of cancer care.
A seat at the table: what the EU HTA reforms really ask of patient involvement
The EU HTA reforms give patients a formal role in assessing new medicines, but meaningful involvement requires more than simply offering them a seat at the table.
Why faster trials make participant understanding more important than ever
As clinical trials accelerate, clear, accessible consent is essential to help participants understand, engage with and remain in a study.
Older trial participants reject bad design, not technology
Older trial participants aren’t rejecting digital technology — they’re rejecting poorly designed, inaccessible experiences that make participation harder.
5 key takeaways from the Patient Centricity and Engagement Conference
Key takeaways from the Patient Centricity and Engagement conference, exploring how trust, inclusion and meaningful partnership can help turn patient engagement from intention into action.
It’s time to stop calling adverse events ‘manageable’
A single word—manageable—can minimise the real burden of treatment side effects, and it’s time clinical trial communication reflected patients’ lived experience more clearly.
The value: why localisation pays off across global trials
Strong localisation reduces trial friction, supports site teams, improves participant understanding and helps global studies run more smoothly, fairly and efficiently.